Cargando…

How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease

Even if amyotrophic lateral sclerosis is still considered an orphan disease to date, its prevalence among the population is growing fast. Despite the efforts made by researchers and pharmaceutical companies, the cryptic information related to the biological and physiological onset mechanisms, as wel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galvez-Llompart, Maria, Zanni, Riccardo, Garcia-Domenech, Ramon, Galvez, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781553/ https://www.ncbi.nlm.nih.gov/pubmed/35056151 http://dx.doi.org/10.3390/ph15010094

Ejemplares similares

Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge
por: Zanni, Riccardo, et al.
Publicado: (2018)

Modeling Natural Anti-Inflammatory Compounds by Molecular Topology
por: Galvez-Llompart, María, et al.
Publicado: (2011)

Molecular Topology QSAR Strategy for Crop Protection: New Natural Fungicides with Chitin Inhibitory Activity
por: Galvez-Llompart, Maria, et al.
Publicado: (2020)

DesMol2, an Effective Tool for the Construction of Molecular Libraries and Its Application to QSAR Using Molecular Topology
por: García-Pereira, Inma, et al.
Publicado: (2019)

Rational Design of Chitin Deacetylase Inhibitors for Sustainable Agricultural Use Based on Molecular Topology
por: Zanni, Riccardo, et al.
Publicado: (2022)

Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors
por: Zanni, Riccardo, et al.
Publicado: (2015)

Application of Molecular Topology for the Prediction of Reaction Yields and Anti-Inflammatory Activity of Heterocyclic Amidine Derivatives
por: Pla-Franco, Jordi, et al.
Publicado: (2011)

COVID-19 and the Importance of Being Prepared: A Multidisciplinary Strategy for the Discovery of Antivirals to Combat Pandemics
por: Galvez-Llompart, Maria, et al.
Publicado: (2022)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Prokaryotic genome regulation: A revolutionary paradigm
por: ISHIHAMA, Akira
Publicado: (2012)

Abnormal topological organization of structural covariance networks in amyotrophic lateral sclerosis
por: Zhang, Yuanchao, et al.
Publicado: (2018)

Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)
por: Ferrer-Donato, Agueda, et al.
Publicado: (2021)

EEG functional network topology is associated with disability in patients with amyotrophic lateral sclerosis
por: Fraschini, Matteo, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

An overview on amyotrophic lateral sclerosis and cadmium
por: Oggiano, Riccardo, et al.
Publicado: (2020)

Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
por: Mavlyutov, Timur A., et al.
Publicado: (2015)

Amyotrophic Lateral Sclerosis (ALS) Awareness Month — May 2013
Publicado: (2013)

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
por: Fournier, Christina N.
Publicado: (2022)

Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis
por: Zhang, Huagang, et al.
Publicado: (2021)

Plasma Uric Acid Helps Predict Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis
por: Tang, Jiahui, et al.
Publicado: (2021)

ALS2 mutations: Juvenile amyotrophic lateral sclerosis and generalized dystonia
por: Sheerin, Una-Marie, et al.
Publicado: (2014)

State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance
por: Wagner, Laurie, et al.
Publicado: (2016)

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
por: Trojsi, Francesca, et al.
Publicado: (2020)

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

MRI Study of Paraspinal Muscles in Patients with Amyotrophic Lateral Sclerosis (ALS)
por: Diamanti, Luca, et al.
Publicado: (2020)

The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
por: Ferrer‐Donato, Agueda, et al.
Publicado: (2021)

Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS)
por: Halliday, Vanessa, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
por: Seki, Soju, et al.
Publicado: (2023)

Artificial Adaptive Systems and predictive medicine: a revolutionary paradigm shift
por: Grossi, Enzo
Publicado: (2010)

Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus
por: Orosco, Fredmoore L.
Publicado: (2023)

The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the (682)YENPTY(687) motif
por: Matrone, Carmela
Publicado: (2023)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4oivsen7san12mubvna0pjd8t1